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 ABSTRACT 
POSTOPERATIVE PAIN AFTER THE USE OF A  
DEXAMETHASONE RINSE AS AN 
IRRIGANT PRIOR TO 
OBTURATION 
 
 
 
Sushant Mahajan, D.M.D. 
 
Marquette University, 2012 
 
 
Purpose: This randomized, single-blind pilot study was to determine the effect of 
dexamethasone on post-operative pain when used as an intracanal rinse prior to 
obturation.  
 
Materials and Methods: Ten adult volunteers were enrolled.  They presented to 
the Marquette University School of Dentistry for endodontic treatment and experienced 
pain from irreversible pulpitis.  The patients were randomly assigned to either the control 
group that received standard of care treatment or the experimental group that received the 
rinse with 4 mg/mL dexamethasone solution prior to obturation.  Before and after 
treatment, the patients recorded their pain level on the numeric rating scale (NRS). 
Recordings were made at baseline, 3, 6, 12, and 24 hours post-operatively. Means and 
standard deviations were calculated.  Treatment effects were analyzed using repeated 
measures ANOVA. Statistical significance was set at p<0.05. 
 
Results: Mean pain levels at baseline were 7.2 and 5.6 for the experimental and 
control groups, respectively.  Patients who received the dexamethasone rinse had mean 
post-operative pain levels of 1.4, 0, 0, and 0 at 3, 6, 12 and 24 hours, respectively.  The 
control group had mean post-operative pain levels of 4.2, 2.6, 2.8, and 1.2 at 3, 6, 12, and 
24 hours, respectively.  Pain level reductions over time were statistically significant 
(p=0.0014).  The overall difference between treatment groups was also statistically 
significant (p=0.0198). 
 
Conclusion: Endodontic treatment using the standard of care approach lead to 
substantial pain relieve within 24 hours.  This was further enhanced if the treatment was 
followed by a rinse with dexamethasone. 
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1 
INTRODUCTION 
 
 
Dentists are employing sedation, nitrous oxide, adequate anesthesia, and oral 
anxiolytics to aid in relaxing their patients and therefore making the treatment less 
threatening and more comfortable.  Postoperative pain following endodontic treatment, 
however, continues to be a frequently observed, detrimental sequela.  In fact, the 
prevalence of moderate to severe postoperative endodontic pain was estimated to be 
between 16 to 25 percent (1-3).  There is also a strong relationship between preoperative 
and postoperative pain.  More than 35 years ago, O’Keefe (1) showed that patients with 
moderate to severe pain prior to treatment were five times more likely to experience 
moderate to severe pain postoperatively.  
Postoperative endodontic pain has been linked to inflammatory reactions that last 
for several days after treatment.  The mechanisms involved in the development of 
postoperative pain are complex; however, it is generally understood that the 
inflammatory response to over instrumentation is one of the major contributing factors 
(4).  Over instrumentation during mechanical debridement can introduce irritants such as, 
microorganisms, bacterial toxins, pulpal degeneration products, as well as caustic 
intracanal irrigants and medicaments into the surrounding periapical tissues (4).  
Inflammation is a defense reaction to the presence of a harmful stimulus.  It is 
characterized by a series of vascular events that depend more upon the severity of the 
injury than the kind of stimulus.  The reaction usually starts with a brief period of 
vasoconstriction that is followed by vasodilation leading to hyperemia and exudation of 
plasma proteins.  Mediators linked to the vascular response and to the initiation of pain 
include prostaglandins, leukotrienes, bradykinin, substance P, and serotonin (5).   
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Glucocorticoids are potent anti-inflammatory agents that suppress the acute 
phenomena of inflammation, such as, edema, fibrin deposition, capillary dilation, and 
migratory and phagocytic activity of leukocytes.  They also stem the chronic 
manifestation of inflammation by reducing proliferation of capillaries, fibroblast, and 
collagen deposition (5).  Glucocorticoids inhibit the synthesis and release of arachidonic 
acid and its metabolites, such as, prostaglandins, thromboxane A2, prostacyclin, and 
leukotrienes.  Along with the above they also inhibit platelet activating factor, tumor 
necrosis factor and interleukin (5). 
Dexamethasone is a synthetic form of the glucocorticoid class of steroid drugs.  It 
is 25 times more potent in reducing inflammation than the naturally occurring cortisol 
hormone (6).  It acts as an anti-inflammatory and immunosuppressant (7).  Like most 
glucocorticoids, it inhibits phospholipase A2 from converting phospholipids to 
arachidonic acid, which is a critical first step in the inflammatory pathway (7).  The 
ability of glucocorticoids to directly and indirectly prevent pain is determined by their 
capacity to suppress the precursors of inflammation and to suppress tissue levels of 
bradykinin (5, 7).  The suppression of these mediators prevents the increase in vascular 
permeability, thereby reducing tissue fluid accumulation with a resultant reduction in 
tissue pressure and pain (8, 9).    
Due to its anti-inflammatory properties, dexamethasone has been used to reduce 
post-treatment swelling and pain following endodontic treatment.  Dexamethasone has a 
plasma half-life of 200 minutes and a tissue half-life of 75 hours (10).  No adverse 
reactions were reported with the use of dexamethasone in a variety of endodontic 
applications (11-15).  Several administration modes of dexamethasone were reported in 
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the past. Krasner and Jackson (11) tested the oral administration (p.o.) of dexamethasone 
or a placebo.  In comparison to patients who received the placebo, the patients who were 
prescribed dexamethasone reported reduced post-treatment endodontic pain 8 and 24 
hours later.  Marshall and Walton (12) injected 4mg/mL of dexamethasone 
intramuscularly (i.m.) at the completion appointment of the endodontic treatment and 
showed significant reduction in post-treatment pain.  They found that significant pain 
reduction occurred after 4 and 24 hours but not after 48 hours.  The recurrence of pain led 
them to conclude that the therapeutic effect of dexamethasone may diminish over time. 
Glassman et al. (13) compared interappointment administration of dexamethasone p.o. 
and a dextrose placebo p.o. in patients with asymptomatic inflamed pulps.  They found 
that dexamethasone effectively inhibited pain between appointments.  Moskow et al. (14) 
were among the first to place a corticosteroid within the root canal to deliver the 
medication locally.  They found a statistically significant difference between the 
dexamethasone group and the placebo group after 24 hours.  Chance et al. (15) also 
placed the medicament within the root canal.  In contrast to the previously mentioned 
authors (11-14), they used prednisolone.  Although prednisolone is less potent inhibitor 
of inflammation than dexamethasone, the results were still encouraging.  Furthermore, 
Chance et al. (15) determined that patients with vital pulp tissue before treatment 
responded to the steroid with less postoperative pain than patient who used placebo.             
The most important difference between the study presented in this thesis and the 
ones conducted by Moskow et al. (14) and Chance et al. (15) is that all endodontic 
treatment was completed in a single appointment.  Along with the advent of rotary 
nickel-titanium systems, improvements in irrigation dynamics and delivery systems have 
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facilitated mechanical instrumentation and disinfection of the root canal.  A recently 
conducted randomized clinical trial compared the more convenient single visit with the 
multiple-visit endodontic treatment.  The study focused on bacteriological outcomes and 
showed no difference in treatment success between the modalities (16).  
Therefore, the purpose of the present study was to determine the effect on post-
operative pain of standard of care endodontic treatment in comparison to standard of care 
plus dexamethasone when used as an intracanal rinse prior to obturation as part of a 
single-visit procedure. 
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MATERIALS AND METHODS 
 
 
A convenience sample of 2 male and 8 female volunteers, with an average age of 
35 years (range: 23-56 years), participated in this prospective, randomized clinical pilot 
study.  Participants were determined to be in good health as per health history and oral 
questioning.  Qualifying patients met the following criteria:  
Inclusion: 
• Older then 18 years of age;  
• Being a patient of record; 
• Vital tooth with a pulpal diagnosis as symptomatic irreversible pulpitis; 
• A pain level of 4 or higher on the numeric rating scale (NRS)  
• Single appointment root canal therapy;  
• Potential to achieve patency in all canals as determined by pre-operative 
radiograph;  
• Able to understand and provide informed consent.   
Exclusion: 
• Radiographic evidence of periapical pathology;  
• Female patients who were pregnant or nursing;  
• History of peptic ulcer or gastrointestinal bleeding;  
• Known hypersensitivity or allergic reactions to non-steroidal anti-
inflammatory drugs or corticosteroids;  
• At risk for renal failure or renal impairment;  
• History of significant medical conditions (American Society of 
Anesthesiologist class II or higher excluded), 
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• Having a recent history of or currently taking anti-inflammatory, 
antibiotic, or narcotic drugs.  
 
The Marquette University Institutional Review Board approved the study 
(Protocol HR-2195, see Appendix), and written informed consent was obtained from 
each patient prior to enrollment.  Any endodontic treatment was completed in the 
morning between 9 a.m. and 4 p.m. to facilitate data collection requirements. 
Teeth included in this study had a diagnosis of symptomatic irreversible pulpitis 
with moderate to severe preoperative pain.  Candidate teeth were tested with Endo-Ice 
(Hydenic Corp, Akron, OH) to determine the pulpal status.  A preoperative radiograph 
was taken at the treatment appointment to rule out periapical pathology.  In addition, a 
comprehensive clinical examination was completed to rule out intra/extraoral swelling, 
presence of a sinus tract, or other major pathology. 
Prior to anesthetizing the treatment area, each patient was asked to rate his or her 
pain on a numeric pain intensity scale otherwise know as a numeric rating scale (NRS) 
(Figure 1).  The scale was from 0, being no pain, to 10, being the worst possible, 
unbearable, excruciating pain.  The NRS score was considered the baseline pain level of 
the patient. 
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Figure 1. A numeric rating scale was used by patients to rate pain levels. 
 
Patients who met all inclusion and none of the exclusion criteria were randomly assigned 
to one of two groups:  
• Group 1 was the experimental group that received the dexamethasone rinse in 
addition to standard of care therapy;  
• Group 2 was the control group who received standard of care therapy only.  
Randomization tables were generated with the aid of the (pseudo) random number 
generator in Microsoft® Excel® for Mac 2011 (Microsoft Corp., Redmond (WA)).  A 
formula was set to randomly select an integer between 1 and 10 without replacement. 
Drawing an even number indicated that the patient would be assigned to Group 1 while 
drawing an odd number resulted in the assignment to Group 2. 
At the initiation of treatment, patients were anesthetized using 1.7- 5.1 mL of 2% 
lidocaine with 1:100,000 epinephrine (Xylocaine; AstraZeneca LP, DENTSPLY, York 
(PA)) via local infiltration or inferior alveolar nerve block, depending on tooth location.  
Prior to beginning the endodontic therapy, anesthesia was confirmed by retesting the 
tooth with Endo-Ice.  After confirmation of complete anesthesia, a rubber dam was 
placed, the occlusion was adjusted and the tooth was accessed.  The working length of 
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the root canal instruments was determined and the canal(s) were prepared with hand and 
rotary instruments.  Each canal was prepared to at least a size #20 hand file, along with 
5.25% sodium hypochlorite (NaOCl) irrigation.  A modified crown-down technique was 
employed to enlarge the canal in the coronal, middle and apical thirds using RaCe 
(Brasseler USA, Savannah (GA)) and EndoSequence (Brasseler USA, Savannah (GA)) 
rotary files.  After the chemo-mechanical cleaning was completed, a final irrigation with 
5.25% NaOCl, 17% ethylenediaminetetraacetic acid (EDTA), and 2% chlorhexidine 
(CHX) was performed.  This was followed by ultrasonic agitation using a size #15 
ultrasonic K-file (Satelec, Merignac, France).  Then, the canal was dried with sterile 
paper points. In Group 2, the canals were obturated as described below.  In Group 1, prior 
to obturation, each canal was rinsed with 1mL of 4 mg/mL dexamethasone sodium 
phosphate aqueous solution (Luitpold Pharmaceuticals, Shirley (NY)).  Patency of the 
canals was rechecked at this point with a hand file of size #10 or greater.  The 
dexamethasone solution was then agitated with a size #15 ultrasonic K-file for 30 
seconds.  The canals were dried again with sterile paper points. 
Obturation was completed by vertical condensation with Brasseler EndoSequence 
.06 ISO sized gutta-percha (Brasseler USA, Savannah (GA)) and AH Plus sealer 
(DeTrey, Dentsply, Ballaigues, Switzerland).  A sterile cotton pellet was placed in the 
pulp chamber and the access opening was sealed with Cavit temporary filling material 
(Cavit G; 3M ESPE, Seefeld, Germany).  All treatment was provided by five residents 
enrolled in the advanced specialty education program in Endodontics at Marquette 
University School of Dentistry. 
9 
 After completion of the endodontic treatment, patients were given post-operative 
forms that included rescue medication instructions, explanation of possible adverse 
events, and pain level score collection instructions.  As rescue medication, all patients 
received 4 tablets of 600mg ibuprofen each, to be taken only if pain levels reached or 
exceeded 6 on the NRS. In addition, if pain was not manageable, patients were informed 
to contact the principal investigator by phone.  Patients were instructed to report also any 
swelling, fever, or persistent infection.  For data collection, patients were requested to 
record NRS values at exactly 3, 6, 12, and 24 hrs post-operatively.  They were also 
instructed to record the amount of rescue medication and when it was taken.  The 
principal investigator contacted the patients 24-hours post-operatively for data collection. 
 In view of the small sample size of this pilot study, statistical analyses were 
limited to computation of means and standard deviations.  In addition, a repeated measure 
analysis of variance was used to investigate overall statistical between-group trends and 
to generate information that could be used for the planning of a pivotal randomized 
clinical trial.  The patient was used as unit for all statistical calculations. Microsoft® 
Excel® for Mac 2011 (Microsoft Corp., Redmond (WA)) and JMP® 9 (SAS Institute Inc. 
Cary (NC)) were used for data analyses and presentations. 
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RESULTS 
 
 
All patients who enrolled on the study also completed it and could be reached 24 
hours post-operatively to obtain all pertinent data.  Teeth available for endodontic 
treatment included 6 molars and 4 premolars.  The patients assigned to the control group 
reported a mean pre-operative pain level of 5.6 ± 1.5 (mean ± 1 standard deviation) as 
assessed using the NRS.  The patients who were randomized to the experimental group 
reported a mean pre-operative pain level of 7.2 ± 1.6.  The difference between treatment 
groups in mean pain levels at baseline was statistically not different (p=0.148).  Nine 
patients reported preoperative percussion sensitivity.  Self-reported pain levels at various 
time intervals over the 24-hour observation period are presented in the table.  
  
 
Patient 
 
Baseline 
 
 
3hrs 
 
6hrs 
 
12hrs 
 
24hrs 
Rescue 
medication 
taken 
Control Group 
Patient 1 5 3 3 3 3 0 
Patient 2 8 4 3 1 1 2 
Patient 3 6 7 3 6 2 2 
Patient 4 5 4 4 0 0 1 
Patient 5 4 3 0 4 0 0 
Experimental Group 
Patient 6 5 0 0 0 0 0 
Patient 7 8 3 0 0 0 1 
Patient 8 9 4 0 0 0 1 
Patient 9 8 0 0 0 0 0 
Patient 10 6 0 0 0 0 0 
Table. Pain level data for patients over a 24-hour period.  
 
 
The mean NRS pain levels of each treatment group, as registered over the 24-hour 
observation period, are shown in Figure 2.  Patients in the experimental group reported 
fewer pain incidents and less post-operative pain than patients in the control group. 
Overall, the mean pain levels of the two treatment groups were statistically significantly 
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different (p=0.0198). In addition, the pain reduction achieved in response to endodontic 
intervention was clinically and statistically highly significant (p=0.0014). 
 
 
Figure 2.  Mean pain levels at the observation intervals for the dexamethasone and 
control group. 
 
 In the experimental group, 3 patients reported they were pain-free at 3 hours post-
operatively.  The other two patients reported mild pain.  All 5 patients reported as being 
pain-free for the remaining observation periods.  Figure 3 represents the NRS pain levels 
as reported by each patient over the 24-hour observation period.  Patients of the control 
group and the experimental group are displayed in the panels on the left side and right 
side, respectively.  
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Five patients reported taking the rescue medication, including 3 patients in the 
control group and 2 patients in the experimental group.  Two of the control group patients 
reported taking the rescue medication twice, once between treatment and 3 hours and the 
second time during the interval between 3 and 6 hours post-operatively.  The third patient 
reported taking the rescue medication also between 3 and 6 hours post-operatively.  The 
patients in the experimental group reported taking the rescue medication between 
treatment and the time they recorded the 3-hour NRS scores. 
All 5 patients of the control group reported mild to moderate pain 3 hours post-
operatively.  Only 2 patients were completely pain-free 24 hours after receiving the 
endodontic treatment.  The other 3 patients reported of mild pain still present. 
The endodontic treatments of all patients were completed uneventfully.  The 
dexamethasone rinse was tolerated well.  No acute adverse side effects, such as swelling, 
were reported during the 24-hour observation period of the study. 
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DISCUSSION 
 
 
 The goal of endodontic therapy is to relieve pain and prevent the systemic spread 
of infections.  Post-operative pain following endodontic treatment of vital teeth most 
likely is caused by a combination of residual inflammatory mediators still present 
immediately following treatment.  Such mediators can be the result of pulpal damage, but 
they can occur also due to over-instrumentation.  Therefore, to control the initiation of 
pain clinically, an effective method would be to inhibit the inflammatory process. 
 With the above in mind this pilot study was conducted to determine if the use of 
dexamethasone as a pre-obturation rinse is effective in reducing post-operative pain.  By 
itself, this is not a novel approach to manage post-operative endodontic pain.  In the past, 
several studies were conducted with the use of a corticosteroid as an intracanal 
medicament (14,15).  However, in these studies the medication was administered at the 
first treatment appointment, after which the tooth was obturated during a second 
appointment, allowing extended contact of the medicament with the periapical tissue.  
The studies clearly showed that post-operative pain was reduced when compared to a 
placebo.  A survey of the members of the American Association of Endodontists showed 
that 55.8 percent of endodontists completed root canal obturation on the first visit in 
cases that presented with irreversible pulpitis (17).  Hence, the novelty of the present 
study as compared to earlier experiments was to conduct the full endodontic treatment, 
including medication and obturation, in a single appointment.  Therefore, the present 
study was conducted to determine if the use of a corticosteroid rinse was still an effective 
treatment modality with the hypothetical reduced contact time with the periapical tissue. 
15 
 The results of the present study suggest that the proposed incorporation of a 
dexamethasone rinse can reduce post-operative pain level and duration in comparison to a 
non-medicated control group.  All subjects of the dexamethasone group showed complete 
pain relief 6 hours post-operatively.  Patients in the control group, on the other hand, 
reported pain present throughout the observation period.  
At baseline, the mean pain level was slightly higher for the experimental group 
than for the control group.  Although the difference was quite large, it was statistically 
not significant and can be explained by chance.  However, this should not be interpreted 
as a failure of the random allocation process used in the study.  Random assignment can 
lead to poorly balanced treatment groups at baseline, in particular when the sample size is 
very small, as was the case in the present study.  
 The present study’s findings agree with the results published by Moskow et al 
(14).  They found that 84 percent of the patients on dexamethasone medication reported 
no pain at the end of the first 24-hour period of observation.  Similarly, Chance et al. (15) 
found that 63 percent of the patients reported no pain after 24 hours even though the less 
potent prednisolone was used.  In both studies, patient monitoring started 24 hours post-
operatively, and therefore the short-term effect of the medication was not studied.  
In the present study, patients in the experimental group noted complete pain relief 
as early as 3 hours post-operatively.  The effect continued until the end of the 24-hour 
observation period.  Even though the observation period was of limited duration, it can be 
hypothesized that the pain relief could last up to 75 hours.  The half-life time  (t½) of 
dexamethasone in connective tissue is about 75 hours, i.e., about 12-times greater than its 
t½ in plasma.  This would indeed support the use of dexamethasone locally as opposed to 
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its systemic administration via plasma delivery.  However, additional studies, extending 
the observation period beyond 72 hours, would be required to validate the claim.    
 Adverse effects inherent to the use of corticosteroids must be considered before 
using the drugs in endodontic practices (18-21).  For example, corticosteroids can 
increase the risks of infection.  In response to this concern, antibiotics have been 
prescribed in combination with steroids (18-21).  However, such an approach appears to 
bear even more risk than using steroids or antibiotics alone.  To minimize the risks of 
infection, this study was restricted to teeth with vital pulps.  Teeth showing periapical 
radiolucency were also excluded because corticosteroids affect bone healing.  In the 
present study, no patient reported fever, malaise, lymphadenopathy, or fluctuant swelling 
with or without the use of the rinse.  However, a much larger study would be needed to 
assess this and other steroid-associated risks. 
 A shortcoming of this study was its small sample size.  In fact, at the onset of 
study planning, a much larger available patient cohort was anticipated.  In hindsight, the 
difficulty to recruit a larger sample was the result of extremely carefully chosen inclusion 
and exclusion criteria, which eliminated many potential study candidates.  One way to 
improve on the recruitment could be to provide an incentive for patients to participate in 
the study.  Another possible improvement to the study would be the use of a double-
blinded treatment approach.  This could be achieved by adding a placebo rinse in the 
control group, such as sterile saline.  Another shortcoming of this study was the selected 
short observation period of 24 hours.  It should be extended to determine the full extent 
of the therapeutic effect of the drug, i.e., to at least 96 hours, assuring that the majority of 
the drug has been eliminated from the periapical tissues.  Similarly, a longer-term follow 
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up on patients would allow studying whether any signs of recurring infection, attributable 
to the use of dexamethasone, can be observed.  Last but not least, the collection of 
patient-generated study information should not be handled over the phone and by the 
principal investigator to assure full compliance with good clinical research practice.  
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CONCLUSION 
 
 
 The findings of this study are encouraging, and corroborate those of similar, 
previously published studies.  The patients on the dexamethasone rinse appeared to show 
a greater decrease in pain levels over the observation period when compared to the 
control group.  A larger study is necessary to allow a more precise assessment of 
dexamethasone-associated effects and side-effects. 
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